메뉴 건너뛰기




Volumn 23, Issue 7, 2006, Pages 569-570

The use of loop diuretics in acute renal failure in critically ill patients to reduce mortality, maintain renal function, or avoid the requirements for renal support

(1)  Carley, Simon D a  

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE; FUROSEMIDE; HYPERTENSIVE AGENT; LOOP DIURETIC AGENT; TORASEMIDE; DIURETIC AGENT;

EID: 33748089308     PISSN: 14720205     EISSN: None     Source Type: Journal    
DOI: 10.1136/emj.2006.038513     Document Type: Short Survey
Times cited : (11)

References (2)
  • 1
    • 3943071113 scopus 로고    scopus 로고
    • Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Diuretics and mortality in acute renal failure
    • Uchino S, Doig GS, Bellomo R, et al. Beginning and Ending Supportive Therapy for the Kidney (B.E.S.T. Kidney) Investigators. Diuretics and mortality in acute renal failure. Crit Care Med 2004;32(8):1669-77.
    • (2004) Crit Care Med , vol.32 , Issue.8 , pp. 1669-1677
    • Uchino, S.1    Doig, G.S.2    Bellomo, R.3
  • 2
    • 0037184416 scopus 로고    scopus 로고
    • Diuretics, mortality, and nonrecovery of renal function in acute renal failure
    • Mehta RL, Pascual MT, Soroko S, et al. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002;288(20):2547-53.
    • (2002) JAMA , vol.288 , Issue.20 , pp. 2547-2553
    • Mehta, R.L.1    Pascual, M.T.2    Soroko, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.